Author: Matthew Nelson|| Date Published: August 7, 2020
An SRI International division has secured a potential seven-year, $100M contract to help a National Institutes of Health component develop methods to medical conditions caused by direct exposure or contamination from radioactive materials.
SRI Biosciences will support the National Institute of Allergy and Infectious Diseases in research and development of medical countermeasures for radiological and nuclear emergencies, the nonprofit said Wednesday.
The partnership will also explore biological dosimetry tests and advance candidate treatments for acute radiation syndromes, delayed effects from acute radiation exposure and internal radionuclide contamination.
Both NIH and NIAID have worked with SRI Biosciences to develop radiation therapies as part of a contract slated to expire this month.
Amentum Mitie Pacific has secured an indefinite-delivery/indefinite-quantity contract with a potential value of $656.4 million to provide base operating support…
CACI International has secured a potential five-year, $416 million SeaPort-Next Generation task order to sustain and modernize information technology systems…
Cherry Bekaert has acquired accounting and advisory firm Tarsus to expand outsourced accounting, real-time financial reporting and strategic chief financial…
General Dynamics Information Technology has received a U.S. Navy contract worth $988 million to modernize and integrate command, control, communications,…
